Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority ...

Revised guidelines propose major improvements in physical infrastructure, air handling units and equipment and machinery.

21 CFR Part 211 details the current good manufacture practice for finished pharmaceuticals ... identity of the component as labeled prior to release for use in drug product manufacturing. The ...

Windlas Biotech added 1.76% to Rs 1,033.15 after the company announced that its new state-of-the-art injectable facility has received Good Manufacturing Practices (GMP) certification.

The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.

In a groundbreaking advancement toward cell therapy and regenerative medicine, the Abu Dhabi Stem Cells Center (ADSCC) has ...

Union Health Ministry extends deadline for pharmaceutical firms to comply with revised Schedule M standards by December 31, ...

a leading European-based Good Manufacturing Practice (GMP) manufacturer. This collaboration will supply Clinical Trial Material (CTM) for Polyrizon’s PL-14 allergy blocker, in preparation for a ...

The Abu Dhabi Stem Cells Center (ADSCC) in the UAE has developed clinical-grade induced pluripotent stem cells (iPSCs) that ...

These companies now have until December 31, 2025, to comply with the improved manufacturing practices. The extension comes following requests from manufacturing units to upgrade their facilities, the ...